Esperion Therapeutics IncEigentümerstruktur
| Preis (2026-07-13) | 52W Hoch | 52W Tief |
| 3.18 USD | 4,18 USD | 1,34 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 3,2 USD | 2 | 2 | 2 | 1 | 0 |
| #Shares | Short [%] | Short Ratio |
| 257.693.347 | 6,87 | 1,58 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Esperion Therapeutics Inc
Mitarbeiter 294
Handelsplatz NASDAQ
Ticker Symbol ESPR
IPO Datum 2013-06-26
Adresse 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108
Webseite https://www.esperion.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Benjamin Halladay M.B.A. | Chief Financial Officer |
| 2 | Mr. John B. Harlow Jr. | Chief Commercial Officer |
| 3 | Mr. Glenn P. Brame | Chief Technical Operations Officer |
| 4 | Mr. Benjamin O. Looker J.D. | Corporate Secretary, Chief Legal & Corporate Affairs Officer |
| 5 | Tiffany Aldrich M.B.A. | Associate Director of Corporate Communications |
| 6 | Ms. Betty Jean Swartz | Chief Business Officer |
| 7 | Dr. Stephen Pinkosky | Vice President of Drug Discovery of Early Pre-Clinical Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Wasatch Advisors LP | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | Two Seas Capital LP | 0,00% | 0,00 Mio. USD |
| 5 | Orbimed Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 8 | Marshall Wace Asset Management Ltd | 0,00% | 0,00 Mio. USD |
| 9 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 10 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 11 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | AIGH Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 14 | Armistice Capital, LLC | 0,00% | 0,00 Mio. USD |
| 15 | Penderfund Capital Management Ltd | 0,00% | 0,00 Mio. USD |
| 16 | Nuveen, LLC | 0,00% | 0,00 Mio. USD |
| 17 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 18 | Two Sigma Advisers, LLC | 0,00% | 0,00 Mio. USD |
| 19 | Privium Fund Management B.V. | 0,00% | 0,00 Mio. USD |
| 20 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |